Our study shows that miR-299-3p targets both AR and VEGFA and could impact multiple pathways involved in cell proliferation, cell survival and EMT simultaneously in both AR-positive and AR-negative PCa cells. The gene discussed is VEGFA; the disease is posterior cortical atrophy.